SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Isotechnika
An SI Board Since August 2001
Posts SubjectMarks Bans Symbol
285 8 0 ISA
Emcee:  schzammm Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
260<<Looks like the way to play this is wait for Roche's decision. ISA wiDaveAu-3/4/2007
259<i>"If Roche comes back in, it would be great. But if they don't,teevee-3/4/2007
258Nice Edmonton Journal Article canada.com:80/edmontonjournal/news/business/storyDaveAu-3/3/2007
257Lux Biosciences Initiates LUMINATE Pivotal Clinical Trials of its Next-Generationigel bates-2/20/2007
256Maybe this will do you and that corn investment some good? virtualmetals.co.uhubris33-1/24/2007
255Head to head with cyclosporine in psoriasis.... EDMONTON, Dec 05, 2006 /PRNewswteevee-12/7/2006
254Isotechnika's lead immunosuppressive drug, ISA247 positioned to enter Phase nigel bates-11/28/2006
253These results look promising. Should enhance the enrollment rate and hopefully D.Lu-11/16/2006
252Isotechnika Announces Initial Data from Phase IIb Kidney Transplant Trial Thursdnigel bates-11/16/2006
251Isotechnika to Announce Initial Data From Phase IIb Kidney Transplant Trial EDMteevee-11/15/2006
250Isotechnika Inc. announces highlights and financial results for third quarter ofteevee-11/14/2006
249Isotechnika successfully extends trial of ISA247 2006-10-05 09:24 ET - News Relteevee-10/5/2006
248Isotechnika Receives Approval From the German Competent Authority for a Pivotal nigel bates-10/2/2006
247Isotechnika Inc. Announces Promising Results From Phase I TAFA93 Trials EDMONTONnigel bates-8/21/2006
246Isotechnika establishes share equity drawdown facility Friday May 26, 9:00 am ETteevee-5/26/2006
245Lux Biosciences Raises $36 Million in Series A Financing and Signs Agreement fornigel bates-5/25/2006
244Isotechnika signs agreement granting Lux Biosciences Worldwide Ophthalmic rightsnigel bates-5/25/2006
243Roche set to abandon ISA247 and Isotechnika? shareholder.com Roche and BioCrysteevee-4/30/2006
242Isotechnika signs option agreement for topical delivery technology of ISA247 4/2teevee-4/29/2006
241OT----> VERY OT! Hope I don't get banned from this board for being so OThubris33-3/31/2006
240Isotechnika Press Release: newswire.caSyncrude-3/20/2006
239WR Hambrecht + Co initiates coverage on Isotechnika wrhambrecht.comteevee-3/18/2006
238Advisory - Isotechnika to Announce Clinical Data From Phase III Psoriasis Trial teevee-3/17/2006
237Isotechnika's Phase III psoriasis trial data to be presented at both the Canteevee-3/2/2006
236Isotechnika Inc. Appoints Franklin M. Berger to its Board of Directors 2/22/2006teevee-2/23/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News